Schoini Pinelopi, Apollonatou Vasiliki, Kallieri Maria, Blizou Myrto, Sfika Maria, Koufopoulos Nektarios, Pouliakis Abraham, Liatsis Emmanouil, Foukas Periklis, Bakakos Petros, Loukides Stelios
ICU, Elpis Hospital, 115 22 Athens, Greece.
2nd Respiratory Department, Attikon University Hospital, National and Kapodistrian University of Athens, 124 62 Athens, Greece.
J Clin Med. 2024 Sep 30;13(19):5836. doi: 10.3390/jcm13195836.
: Sensitization to specific IgE enterotoxins (SEs) is associated with an increased risk for severe asthma development. Limited data exist regarding the association of seropositivity for specific IgE SEs and the different aspects of severe asthma. We aimed to determine whether the presence of SEs is associated with asthma-related parameters such as inflammatory cells in the airways, features of airway remodeling, and other variables relating to asthma assessment and severity. : Fifty patients with severe asthma were recruited in the study. Demographics, comorbidities, asthma duration, and asthma medication were recorded by treating physicians. Specific IgE SE measurement, lung function, atopic status, asthma control test (ACT), sputum induction, bronchoscopy with BAL, and indices of airway remodeling were also assessed. : Twelve patients were positive to enterotoxin sensitization. Patients seropositive to specific IgE SEs significantly differed in regard to FEV% pred and FEV/FVC ratio compared to seronegative ones. Analyzing the inflammatory variables obtained from induced sputum, BAL, and endobronchial biopsies, the only significant difference was that of smooth muscle area (SMA), which was greater in specific IgE SE seropositive patients. The multivariate linear regression analysis showed two significant associations of specific IgE SE seropositivity. We found a negative with FEV% pred with beta standardized coefficient 95%CI -0.054 (-0.083, -0.031), < 0.001, and a positive with SMA with beta standardized coefficient 95%CI 0.054 (0.081, 0.037), < 0.001. : Seropositivity to specific IgE SEs in severe asthma is associated with more severe airflow limitation, obstruction, and upregulation in SMA, indicating a possible role in the remodeling process.
对特定IgE肠毒素(SEs)致敏与严重哮喘发生风险增加相关。关于特定IgE SEs血清阳性与严重哮喘不同方面的关联,现有数据有限。我们旨在确定SEs的存在是否与哮喘相关参数有关,如气道中的炎症细胞、气道重塑特征以及与哮喘评估和严重程度相关的其他变量。:本研究招募了50例严重哮喘患者。治疗医生记录了人口统计学、合并症、哮喘病程和哮喘用药情况。还评估了特定IgE SE测量、肺功能、特应性状态、哮喘控制测试(ACT)、痰液诱导、支气管镜检查及支气管肺泡灌洗(BAL)以及气道重塑指标。:12例患者对肠毒素致敏呈阳性。与血清阴性患者相比,特定IgE SEs血清阳性患者在FEV%预计值和FEV/FVC比值方面存在显著差异。分析从诱导痰液、BAL和支气管活检获得的炎症变量,唯一显著差异是平滑肌面积(SMA),在特定IgE SE血清阳性患者中更大。多变量线性回归分析显示特定IgE SE血清阳性存在两个显著关联。我们发现与FEV%预计值呈负相关,标准化β系数95%CI为 -0.054(-0.083,-0.031),P < 0.001,与SMA呈正相关,标准化β系数95%CI为0.054(0.081,0.037),P < 0.001。:严重哮喘患者对特定IgE SEs血清阳性与更严重的气流受限、阻塞以及SMA上调相关,表明其在重塑过程中可能发挥作用。